Pfizer

Pfizer’s ‘virtual’ clinical trial could have far-reaching implications for future research productivity

Monday, June 20, 2011 08:00 AM

As Pfizer begins enrolling the first-ever FDA-approved “virtual” clinical trial, which allows patients to participate from home using smartphones and computers instead of visiting a clinic, industry executives believe the study has far-reaching implications for improving the productivity of clinical trials in the future.

More... »

Pfizer puts Sandwich R&D site on market

Tuesday, June 14, 2011 02:28 PM

Pfizer's giant research base at Sandwich, southern England, has been officially put on the market by CB Richard Ellis, according to Reuters. U.S.-based Pfizer in February decided to close the site.

More... »

Strategic partnerships: a good deal for CROs, or just a cost-cutting measure by big pharma?

Monday, June 13, 2011 08:01 AM

Strategic partnerships with the top 20 pharma companies are what most sizable CROs dream of these days.

More... »

Boston's Top AMCs Join Pfizer's Centers For Therapeutic Innovation

Thursday, June 9, 2011 12:42 PM

Pfizer’s network of translational research partnerships, called the Centers for Therapeutic Innovation, has launched in Boston with Beth Israel Deaconess Medical Center, Boston University School of Medicine, Children's Hospital Boston, Harvard University, Partners HealthCare, Tufts Medical Center, Tufts University and the University of Massachusetts Medical School in Worcester.

More... »

Pfizer chooses Icon and Parexel as its two strategic outsourcing partners in 5-year deals

Monday, June 6, 2011 10:23 AM

Strategic partnerships with large pharma recently have become the holy grail among CROs. And two have been awarded by Pfizer, the largest drug maker in the world.

More... »

Pfizer still seeking CROs for U.K. site

Thursday, June 2, 2011 11:21 AM

Pfizer continues to search for CROs to occupy a U.K. site, but the local council is disappointed by the lack of government action.

More... »

Pfizer strategically partners with Icon, Parexel

Thursday, May 26, 2011 11:53 AM

Pfizer today doled out two large strategic partnership agreements, which have become the brass ring for which most CROs medium and large are jockeying.

More... »

Pfizer's rheumatoid arthritis pill impresses experts despite study deaths

Wednesday, May 25, 2011 12:31 PM

Pfizer's new rheumatoid arthritis pill impressed experts at a medical meeting in London today, despite four deaths in a study that spooked investors last month, according to Reuters.

More... »

Pfizer files NDA for new oncology drug

Wednesday, May 18, 2011 12:07 PM

Pfizer has filed a new drug application for its oncology drug crizotinib with regulators in the U.S. and Japan.

More... »

Rigel assumes development responsibility for R343

Friday, May 6, 2011 12:37 PM

Rigel Pharmaceuticals will assume development of R343, its inhaled syk inhibitor for allergic asthma that recently completed several phase I clinical trials. Pfizer is returning full rights to the R343 program as a result of its decision to exit the allergy and respiratory therapeutic area within R&D.  Rigel is evaluating the details of R343's development to date and expects to design a phase II clinical trial with R343 later this year.

More... »